St. Johns Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.82M Buy
15,158
+744
+5% +$85.9K 0.77% 32
2025
Q4
$1.52M Sell
14,414
-927
-6% -$87K 0.63% 39
2025
Q3
$1.29M Sell
15,341
-1,354
-8% -$112K 0.55% 44
2025
Q2
$1.32M Buy
16,695
+275
+2% +$21.9K 0.61% 39
2025
Q1
$1.47M Sell
16,420
-997
-6% -$93.1K 0.73% 39
2024
Q4
$1.73M Buy
17,417
+731
+4% +$75.4K 0.81% 33
2024
Q3
$1.89M Sell
16,686
-17
-0.1% -$2.02K 0.89% 29
2024
Q2
$2.07M Buy
16,703
+533
+3% +$68.7K 0.98% 28
2024
Q1
$2.13M Buy
16,170
+74
+0.5% +$9.12K 1.02% 27
2023
Q4
$1.75M Sell
16,096
-38
-0.2% -$3.94K 0.9% 29
2023
Q3
$1.66M Buy
16,134
+25
+0.2% +$2.69K 0.95% 27
2023
Q2
$1.86M Sell
16,109
-527
-3% -$59.8K 1.01% 26
2023
Q1
$1.77M Sell
16,636
-963
-5% -$104K 1.03% 25
2022
Q4
$1.95M Sell
17,599
-365
-2% -$37.3K 1.16% 21
2022
Q3
$1.55M Buy
17,964
+643
+4% +$57.4K 1.02% 24
2022
Q2
$1.58M Sell
17,321
-81
-0.5% -$7.18K 1% 26
2022
Q1
$1.43M Buy
17,402
+1,071
+7% +$84.4K 0.76% 39
2021
Q4
$1.25M Buy
16,331
+862
+6% +$68.7K 0.64% 50
2021
Q3
$1.16M Buy
15,469
+495
+3% +$37.6K 0.64% 50
2021
Q2
$1.17M Sell
14,974
-100
-0.7% -$7.44K 0.63% 49
2021
Q1
$1.11M Buy
15,074
+844
+6% +$62.3K 0.64% 51
2020
Q4
$1.11M Sell
14,230
-967
-6% -$74K 0.69% 47
2020
Q3
$1.2M Sell
15,197
-750
-5% -$58.7K 0.81% 41
2020
Q2
$1.18M Buy
15,947
+1,291
+9% +$97.2K 0.86% 38
2020
Q1
$1.08M Sell
14,656
-938
-6% -$73.7K 0.96% 32
2019
Q4
$1.35M Sell
15,594
-1,570
-9% -$129K 0.94% 33
2019
Q3
$1.38M Sell
17,164
-1,520
-8% -$122K 1.03% 31
2019
Q2
$1.5M Buy
18,684
+92
+0.5% +$7.04K 1.11% 26
2019
Q1
$1.48M Buy
18,592
+324
+2% +$24.2K 1.14% 26
2018
Q4
$1.33M Sell
18,268
-2
-0% -$141 1.18% 26
2018
Q3
$1.24M Sell
18,270
-1,411
-7% -$89.9K 0.93% 36
2018
Q2
$1.14M Buy
19,681
+494
+3% +$27.9K 0.84% 40
2018
Q1
$997K Buy
19,187
+76
+0.4% +$4.11K 0.75% 43
2017
Q4
$1.03M Sell
19,111
-331
-2% -$18.4K 0.76% 44
2017
Q3
$1.19M Sell
19,442
-366
-2% -$22.2K 0.87% 32
2017
Q2
$1.21M Buy
19,808
+595
+3% +$36.2K 0.91% 33
2017
Q1
$1.17M Sell
19,213
-309
-2% -$18.7K 0.92% 31
2016
Q4
$1.1M Sell
19,522
-134
-0.7% -$7.84K 0.91% 35
2016
Q3
$1.17M Buy
19,656
+478
+2% +$28K 0.98% 30
2016
Q2
$1.05M Buy
19,178
+372
+2% +$19.8K 0.95% 35
2016
Q1
$949K Buy
18,806
+473
+3% +$23.2K 0.84% 37
2015
Q4
$924K Buy
18,333
+99
+0.5% +$4.99K 0.83% 39
2015
Q3
$859K Buy
18,234
+401
+2% +$21.3K 0.81% 40
2015
Q2
$969K Buy
17,833
+451
+3% +$25.3K 0.83% 37
2015
Q1
$953K Sell
17,382
-171
-1% -$9.68K 0.83% 40
2014
Q4
$951K Sell
17,553
-304
-2% -$16.9K 0.82% 42
2014
Q3
$1.01M Buy
17,857
+65
+0.4% +$3.65K 0.89% 33
2014
Q2
$982K Buy
17,792
+142
+0.8% +$7.75K 0.84% 40
2014
Q1
$956K Buy
+17,650
New +$914K 0.86% 39

Other funds holding MRK

St. Johns Investment Management's MRK Position: Q1 2026 in Review

St. Johns Investment Management increased its Merck (MRK) stake by 5.2% in Q1 2026, buying an estimated $85.9K and bringing the position to 15,158 shares worth $1.82M. The position accounts for 0.77% of the portfolio, ranked #32.

St. Johns Investment Management first reported a position in MRK in Q1 2014 and has held it in 49 quarters since. The position peaked at $2.13M in Q1 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • St. Johns Investment Management held 15,158 shares of Merck worth $1.82M as of Q1 2026.
  • St. Johns Investment Management bought 744 Merck shares in Q1 2026, an estimated $85.9K.
  • Merck made up 0.77% of St. Johns Investment Management's portfolio in Q1 2026, its #32 holding.
  • St. Johns Investment Management first reported a position in Merck in Q1 2014 and has held it in 49 quarters since.
  • St. Johns Investment Management's Merck position peaked at $2.13M in Q1 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on St. Johns Investment Management's 13F filing for Q1 2026, filed 28 Apr 2026.